Acalabrutinib
Update Venetoclax in CLL
Obinutuzumab
Zanubrutinib
Leukemia & Lymphoma Society
UpToDate
ASH: COVID-19 Resources for Managing Blood Cancers
NCCN Guidelines for Patients